Many countries continue to experience pertussis epidemics despite widespread vaccination.
Waning protection after booster vaccination has highlighted the need for a better …

Bordetella pertussis (Bp), the causative agent of pertussis, continues to circulate despite
widespread vaccination programs. An important question is whether and how (sub) clinical …

Pertussis (whooping cough) is frequently complicated by concomitant infections with
respiratory viruses. Here we report the effect of Bordetella pertussis infection on subsequent …

Background Tetanus, diphtheria, acellular pertussis, inactivated polio (Tdap-IPV) vaccines
administered during pregnancy protect young infants from Bordetella pertussis (B. pertussis) …

Vaccines against pertussis have been available for more than 60 years. Nonetheless, this
highly contagious disease is reemerging even in countries with high vaccination coverage …

The increased incidence of whooping cough worldwide suggests that current vaccination
against Bordetella pertussis infection has limitations in quality and duration of protection …

Bordetella Pertussis (BP) vaccine-induced immunity is waning worldwide despite excellent
vaccine coverage. Replacement of the whole-cell inactivated vaccine (wP) by an acellular …

The immune response elicited by the protective whole‐cell pertussis (wP) versus the less‐
protective acellular pertussis (aP) vaccine has been well characterized; however, important …

Background Recombinant pertussis vaccines inducing long-lasting immune responses
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …

The incidence of whooping cough due to Bordetella pertussis (BP) infections has increased
recently. It is believed that the shift from whole-cell pertussis (wP) vaccines to acellular …